topathological, immunophenotypic, and genotypic analysis. Cancer (WHO-EORTC) classification for cutaneous lymphoma was established and the term "SPTL" was used only in α/β T-cell phenotype while cases with U/δ T-cell phenotype were classified as cutaneous U/δ T-cell lymphoma. 8, 9 Few studies that fulfill the WHO-EORTC classification have been reported, probably because of new definition and a rarity of disease, which occurs in approximately 1% of patients with cutaneous lymphoma. 8 Therefore, we performed clinicopathologic, immunophenotypic, and T-cell receptor (TCR) gene rearrangement studies of SPTL to identify features helpful in the diagnosis of SPTL and its prognosis.
| METHODS

Eighteen patients diagnosed with SPTL between January 2007 and
December 2016 were identified through electronic medical database of Ramathibodi Hospital, Bangkok, Thailand. Clinicopathologic and immunophenotypic analysis were intensely reviewed by one hematopathologist and one dermatopathologist, using the WHO-EORTC classification for cutaneous lymphoma. Laboratory investigations including blood chemistry, complete blood count, lactate dehydrogenase (LDH), computed tomography (CT) scan of chest and abdomen, and bone marrow biopsy were performed in all patients to evaluate for systemic involvement. This study finally included 16 patients with SPTL. Two patients were excluded because lack of immunohistochemical studies. Data from medical record included age at diagnosis, comorbidities, presentation, treatment, response, and prognosis.
| Histopathology and immunohistochemistry
Hematoxylin and eosin-stained sections of paraffin-embedded formalin-fixed skin tissue were examined by light microscopy. The following histopathological characteristics were reviewed: distribution and pattern of infiltrate, cytological composition (lymphocytes, neutrophils, eosinophils, and plasma cells), cytophagocytosis, angioinvasion, and fat necrosis. For plasma cells, we defined the term "significant proportion of plasma cells" if focal aggregation of plasma cells were more than or equal to 10 cells/high power field. To exclude coexisting lupus panniculitis, we performed staining for mucin and plasmacytoid dendritic cells using Alcian blue pH 2.5 and antibody to CD 123 (Leica clone BR4MS), respectively.
| In situ hybridization for Epstein-Barr virus detection
Epstein-Barr virus (EBV) in situ hybridization was performed on routinely fixed paraffin-embedded tissue specimens with the positive control, using the Ventana Benchmark autostainer and the EBV early RNA (EBER) kit (Ventana Medical Systems, Tuscon, Arizona).
| T-cell receptor gene rearrangement studies
Polymerase chain reaction analysis of the T-cell receptor gamma (TCR U) chain gene rearrangement was performed on routinely fixed paraffin-embedded tissue specimens according to standard BIOMED-2 procedures. 
| Survival and statistical analysis
The overall survival was calculated from the date of histologically confirmed diagnosis until death or last follow-up. Survival analysis was performed using the Kaplan-Meier method and the log-rank test. Four patients were previously diagnosed as lupus erythematosus panniculitis (LEP) (two patients) and erythema nodosum (EN) (two patients). Two patients lacked immunohistochemical studies of previous specimens; therefore, a final diagnosis could not be obtained. The remaining two patients (one with LEP and one with EN) were proven later to have a diagnosis of SPTL.
| Histopathology
Histopathological characteristics of patients with SPTL are summarized in Table 2 . All patients had predominantly subcutaneous infiltrate of small-to medium-sized atypical lymphocytes, most with lobular pattern ( Figure 2 ) and only one patient had mixed panniculitis. with varying numbers was found in all patients; however, a significant proportion of plasma cells (≥ 10 cells/HPF) was only observed in three patients ( Figure 3 ). In two patients, there was extension of the infiltrate into the dermis with periadnexal involvement, while three patients had epidermal change in vacuolar alteration of basal cell layer ( Figure 4 ). Neutrophils were rare and observed only in two patients.
Eosinophils were absent. No angioinvasion or angiocentric infiltrate was observed.
| Immunohistochemical and TCR gene rearrangement studies
Immunohistochemical and TCR gene rearrangement studies are summarized in Table 3 . In all cases, individual fat cells were rimmed by atypical lymphocytes positive for CD3, CD8, granzyme B, and βF1, with high Ki-67 index (50%-90%) and negative for CD20, CD56, TCR gamma, and EBER stains (Figures 5 and 6 ). All but one case showed CD4 negativity. Half of the patients showed monoclonal rearrangement of the TCR gamma gene. 
| Treatment, response, and survival analysis
Our study was performed in a tertiary care center; almost all cases were referrals that were initially treated with immunosuppressive drugs, such as prednisolone, cyclosporine, and azathioprine. Once the diagnosis of SPTL was validated by skin biopsy, patients were sent to a hematologist to treat and evaluate for bone marrow involvement. Of the 16 SPTL patients, 9 patients had complete response, only 2 patients had progressive disease, 4 patients were in the periods of treatment and one was lost to follow-up. Among patients who initially had complete response, two patients had disease recurrence. One died because of septic shock after receiving chemotherapy and the other from severe HPS. Of the two patients with progressive disease, one died of severe HPS and the other was lost to follow-up. In survival analysis, the mortality in patients with upper extremity lesions was higher than those who had no upper extremity involvement (4.1%/month vs 0.4%/month, P = 0.01). However, the extent of skin involvement, type of treatment, and the presence of HPS were not significantly related to survival. One-year overall survival rate was 93.8% with a median follow-up period of 17 months (1-90 months).
| DISCUSSION
We reviewed 16 patients with an initial diagnosis of SPTL using clinicopathologic features, immunohistochemistry, TCR gene rearrangement, treatment, and clinical courses. In our study, patients were young, with female predominance. Almost all patients had presenting skin findings accompanied by fever. The most common skin manifestation was subcutaneous nodules and/or plaques (93.8%), predominantly on the lower extremities similar to previous studies in Europe, 12 China, 13 and Japan, 14 while in Korea, skin lesions were most common on the trunk. 15 In this series, we also found two patients with an unusual clinical presentation of facial swelling. Lee et al. studied cases of cutaneous lymphoma presenting with facial swelling 16 and found that extranodal natural killer (NK)/T-cell lymphoma was the most common cause in primary cutaneous lymphoma, while SPTL, hydroa vacciniforme-like lymphoma, and peripheral T-cell lymphoma were also noted. 16 Therefore, a high index of suspicion of cutaneous lymphoma including SPTL is critical, especially in patients with refractory facial swelling. Moreover, lipoatrophy accompanied with subcutaneous nodules has been noted in three patients.
In addition, one patient (case 2) in our study had no skin lesion.
She initially presented with prolonged fever and lymphadenopathy.
Lymph node biopsy showed reactive hyperplasia. LDH level was high (1201 U/L). The provisional diagnosis was intravascular lymphoma.
Three random skin biopsies (from both inner thighs and abdomen)
were performed and revealed the diagnosis of SPTL.
In contrast to previous studies, our patients tend to have more systemic involvement. Hepatosplenomegaly was reported in 50%, while previous reports showed incidence ranging from 4.5% to 31%. 12, 13, 15 Lymphadenopathy was found in nearly 40% in our study and the Korean study, 15 8% of patients in the European study, 12 and none in the Chinese study. 13 HPS was found in 37.5% of our study, 45.5% of the Japanese study, 14 17% in the European study, 12 14% in the Korean study, 15 and 0% of Chinese study. 13 Furthermore, bone marrow involvement, which is not common, was found in approximately 19% of our patients, no report in European, 12 Chinese 13 and Korean patients. 15 This difference LDH was reported in nearly 100% of our patients and nearly three to fourths of patients in Japan 14 and Korea. 15 Clinical comparison between our SPTL patients and previous studies is summarized in Table 4 .
Of note, all patients had α/β T-cell phenotype confirmed by the expression of βF-1. Our patients also had positive staining of CD8 and granzyme B indicating cytotoxic T-cell in nature. Exclusion of U/δ Tcell lymphoma and extranodal NK/T-cell lymphoma was evident through negative TCR gamma and EBER stains. Although most SPTL This may be because of identification of only gamma clonal TCR gene rearrangement and poor tissue quality. At our center, we found that paraffin tissue block stored more than 2 years commonly had DNA degradation and lead to false negative on TCR gene rearrangement.
Interestingly, one patient in our study was initially diagnosed with LEP which was later was proven to be SPTL. The original diagnosis was previously based on histopathological findings with a lack of immunohistochemical and molecular studies. Of note, Ki-67 staining was found to be as high as 50% to 90% positive in atypical cytotoxic CD8 + T-cells in our study. These findings were similar to LeBlance et al. 10 study which reported >30% Ki-67 staining positive, confirming Ki-67 staining is highly specific for diagnosis of SPTL as opposed to LEP.
With regards to prognosis, SPTL has been associated with a favorable prognosis and protracted clinical course with a 5-year survival rate of 80%. 12 The presence of HPS and angioinvasion has been reported to be indicators of poor prognosis. 12,13 Although we had a high rate of HPS and systemic involvement, these factors were not associated with mortality. Interestingly, location on the upper extremities indicated a worse prognosis.
This study had limitations. First, the number of patients included was small because of rarity of the disease. Second, the follow-up period was too short to estimate a 5-year overall survival rate. Third, poor quality of tissue specimens leads to false negative TCR. Finally, patients were collected in a tertiary care center represent cases with more systemic involvement and required more aggressive treatment than typically indolent SPTL. This could potentially cause selection bias.
In conclusion, patients with SPTL present with variable clinical manifestations. Subcutaneous nodules/plaques are the most common presentation, with or without accompanying facial swelling and lipoatrophy. It is difficult to differentiate SPTL from LEP using clinical presentation alone. Therefore, clinicopathologic and immunophenotypic correlation is important in the diagnosis of SPTL. TCR gene rearrangement may be used as an adjunctive tool but highly positive Ki-67 is extremely useful in differentiating SPTL from LEP.
